Evidence method
Level · gp.fundamentals.debt_to_revenue
39.71% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ATRC · Jun 30, 2026
AtriCure, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001323885-26-000035General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.45% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.45% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
12.83% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
54.64% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
77.23% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
6.29% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.19% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
8.02% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History55 statesSelf-history eligible
Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20249/9 normalizedLevel 3Jun 30, 20249/9 normalizedLevel 3Sep 30, 20249/9 normalizedLevel 3Dec 31, 20249/9 normalizedLevel 3Mar 31, 20259/9 normalizedLevel 3Jun 30, 20259/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 43.19%
- Current
- 39.71%
- Delta
- -3.47%
- Previous
- 2.73%
- Current
- 2.45%
- Delta
- -0.28%
- Previous
- -2.83%
- Current
- 14.45%
- Delta
- 17.28%
- Previous
- 14.26%
- Current
- 12.83%
- Delta
- -1.43%
- Previous
- 57.45%
- Current
- 54.64%
- Delta
- -2.81%
- Previous
- 77.39%
- Current
- 77.23%
- Delta
- -0.16%
- Previous
- 0.37%
- Current
- 6.29%
- Delta
- 5.92%
- Previous
- 17.16%
- Current
- 17.19%
- Delta
- 0.03%
- Previous
- 7.98%
- Current
- 8.02%
- Delta
- 0.04%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 84%
- Compared
- 7 dimensions
- Coverage
- 78%
- Similarity
- 83%
- Compared
- 8 dimensions
- Coverage
- 89%
- Similarity
- 82%
- Compared
- 9 dimensions
- Coverage
- 100%
- Similarity
- 77%
- Compared
- 9 dimensions
- Coverage
- 100%
- Similarity
- 73%
- Compared
- 9 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Analogous To · ATRC state analogue 4 →Compared To · Surgical & Medical Instruments & Apparatus peers →Analogous To · ATRC state analogue 2 →Analogous To · ATRC state analogue 5 →Analogous To · ATRC state analogue 1 →Analogous To · ATRC state analogue 3 →Derived From · ATRC Company Quality Vector →Has State · AtriCure, Inc. →Transitioned To · ATRC historical state 2026-03-31 →Transitioned To · ATRC BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ATRC CAPEX_INTENSITY_DECREASED →Transitioned To · ATRC CASH_GENERATION_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.